Glyriva Inhalation Capsule 50 mcg contains Glycopyrronium Bromide, a long-acting antimuscarinic bronchodilator used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is designed to provide sustained bronchodilation, helping patients breathe more easily and improve overall lung function. Glyriva is not intended for the relief of acute bronchospasm but is suitable for long-term daily management of COPD symptoms.

Glyriva Inhalation Capsule is administered via a suitable dry powder inhaler device, ensuring targeted drug delivery directly to the lungs with minimal systemic exposure.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

Long-Acting Muscarinic Antagonist (LAMA)

Pharmacology

Glycopyrronium Bromide works by selectively blocking muscarinic M3 receptors in the airway smooth muscles. This inhibition prevents acetylcholine-mediated bronchoconstriction, leading to relaxation of bronchial smooth muscles and sustained airway dilation. The result is improved airflow, reduced airway resistance, and relief from symptoms such as breathlessness.

Glycopyrronium has a rapid onset of action and a prolonged duration of bronchodilation, allowing once-daily administration. Due to its quaternary ammonium structure, systemic absorption is limited, reducing the risk of systemic anticholinergic side effects.

Indications

Glyriva Inhalation Capsule 50 mcg is indicated for:

• Maintenance treatment of chronic obstructive pulmonary disease (COPD)

• Long-term management of airflow limitation

• Reduction of COPD-related symptoms such as dyspnea

Dosage and Administration

The recommended dose is one inhalation capsule (50 mcg) once daily, inhaled using an appropriate dry powder inhaler device. The capsule is for inhalation use only and must not be swallowed. Patients should be instructed on proper inhalation technique to ensure optimal drug delivery. Treatment should be continued regularly for maximum benefit.

Benefits and Features

• Provides sustained bronchodilation for 24 hours

• Improves lung function and exercise tolerance

• Reduces breathlessness and COPD symptoms

• Once-daily dosing enhances patient compliance

• Minimal systemic side effects due to targeted lung delivery

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Use in Special Populations

• Elderly patients: Generally well tolerated; no dose adjustment usually required

• Renal impairment: Use with caution in severe renal dysfunction

• Pregnancy and lactation: Use only if clearly needed and under medical supervision

Side Effects

Glyriva Inhalation Capsule is usually well tolerated. Possible side effects may include:

• Dry mouth

• Cough or throat irritation

• Headache

• Nasopharyngitis

Serious anticholinergic effects are rare when used at recommended doses.

Precautions and Warnings

• Not intended for acute relief of bronchospasm

• Use with caution in patients with narrow-angle glaucoma or urinary retention

• Do not swallow the capsule

• Regular monitoring of respiratory status is recommended

Storage

Store in a cool and dry place below 30°C. Protect from moisture. Keep capsules in the blister pack until use. Keep out of reach of children.